NL23522C
(ko)
|
1927-03-23 |
|
|
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
FI83662C
(fi)
|
1980-07-17 |
1991-08-12 |
Scripps Clinic Res |
Diagnostik antikropp och foerfarande foer dess framstaellning.
|
IL61904A
(en)
|
1981-01-13 |
1985-07-31 |
Yeda Res & Dev |
Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
ZA836080B
(en)
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
US4625015A
(en)
|
1982-08-23 |
1986-11-25 |
Scripps Clinic & Research Foundation |
Broad spectrum influenza antisera
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
JP2518607B2
(ja)
|
1985-08-29 |
1996-07-24 |
雪印乳業株式会社 |
インフルエンザa型ウイルスha抗原に対するモノクロ―ナル抗体およびその作成方法
|
ATE71292T1
(de)
|
1987-03-13 |
1992-01-15 |
Micro Vesicular Systems |
Lipidversikel aus grenzflaechenaktiven stoffen und sterolen.
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
WO1989011298A1
(en)
|
1988-05-27 |
1989-11-30 |
Centocor, Inc. |
Formulation for antibody reagents
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
GB9320597D0
(en)
|
1993-10-06 |
1993-11-24 |
Proteus Molecular Design |
Improvements in and realting to vaccines
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
JP2996864B2
(ja)
|
1994-03-30 |
2000-01-11 |
寳酒造株式会社 |
抗体可変領域dna
|
DE19643314A1
(de)
|
1996-10-21 |
1998-04-23 |
Boehringer Mannheim Gmbh |
Monoklonale Antikörper gegen das Epitop YPYDVPDYA, Verfahren zu deren Herstellung und Verwendung
|
FR2817869B1
(fr)
|
2000-12-07 |
2005-01-14 |
Technopharm |
Anticorps monoclonal humain dirige contre le virus influenza ou un fragment de celui-ci
|
KR100960560B1
(ko)
|
2002-09-27 |
2010-06-03 |
젠코어 인코포레이티드 |
최적화된 Fc 변이체 및 그의 제조 방법
|
WO2004076621A2
(en)
|
2003-02-27 |
2004-09-10 |
Yeda Research And Development Co. Ltd. |
Compositions of nucleic acids for treating and detecting influenza virus
|
CA2816222A1
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
ES2562912T5
(es)
|
2003-10-01 |
2020-02-18 |
Kyowa Hakko Kirin Co Ltd |
Procedimiento de estabilización de un anticuerpo y preparación de anticuerpo de tipo disolución estabilizada
|
DK2261375T3
(da)
|
2003-11-04 |
2013-04-22 |
Univ Tulane |
Fremgangsmåde til hindring af viruscellefusion ved hæmning af funktionen af fusionsinitieringsområdet i RNA-vira med klasse I membranfusogene kappeproteiner
|
EP2385069A3
(en)
|
2003-11-12 |
2012-05-30 |
Biogen Idec MA Inc. |
Neonatal Fc rReceptor (FcRn)- binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
|
WO2005063815A2
(en)
|
2003-11-12 |
2005-07-14 |
Biogen Idec Ma Inc. |
Fcϝ receptor-binding polypeptide variants and methods related thereto
|
CA2566355C
(en)
|
2004-05-18 |
2014-04-15 |
Vical Incorporated |
Influenza virus vaccine composition and methods of use
|
ES2454266T3
(es)
|
2004-05-25 |
2014-04-10 |
Medimmune, Llc |
Variantes de la hemaglutinina y la neuraminidasa de influenza
|
CA2591992A1
(en)
*
|
2004-12-22 |
2006-06-29 |
The Salk Institute For Biological Studies |
Compositions and methods for producing recombinant proteins
|
US7572620B2
(en)
|
2005-01-11 |
2009-08-11 |
Wisconsin Alumni Research Foundation |
H3 equine influenza A virus
|
EP1851238A4
(en)
|
2005-02-24 |
2008-12-31 |
Univ Massachusetts |
FLUID NUCLEIC ACIDS, POLYPEPTIDES AND USES THEREOF
|
CA2637837A1
(en)
|
2006-01-26 |
2007-08-09 |
Hx Diagnostics, Inc. |
Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
|
US8222204B2
(en)
|
2006-05-03 |
2012-07-17 |
The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC |
Influenza inhibiting compositions and methods
|
AU2007249160B2
(en)
|
2006-05-15 |
2013-09-12 |
I2 Pharmaceuticals, Inc. |
Neutralizing antibodies to influenza viruses
|
BRPI0713671A2
(pt)
|
2006-06-16 |
2013-12-03 |
Dow Agrosciences Llc |
Sequências de dna, vetores e proteínas de hemaglutinina de influenza aviária
|
PL2059532T3
(pl)
|
2006-09-07 |
2013-05-31 |
Crucell Holland Bv |
Ludzkie cząsteczki wiążące zdolne do neutralizowania wirusa grypy H5N1 i ich zastosowania
|
WO2008033105A1
(en)
|
2006-09-13 |
2008-03-20 |
Dso National Laboratories |
Hemagglutinin antibody and uses thereof
|
JP4625485B2
(ja)
|
2006-09-29 |
2011-02-02 |
財団法人大阪産業振興機構 |
高病原性トリインフルエンザウイルスに対するモノクローナル抗体
|
WO2008091657A1
(en)
|
2007-01-23 |
2008-07-31 |
Academia Sinica |
Flu vaccines and methods of use thereof
|
JP5346820B2
(ja)
|
2007-03-13 |
2013-11-20 |
エイチユーエムエイビーエス・リミテッド・ライアビリティ・カンパニー |
H5n1亜型a型インフルエンザウィルスに対する抗体
|
MX2009009912A
(es)
|
2007-03-27 |
2010-01-18 |
Sea Lane Biotechnologies Llc |
Constructos y colecciones que comprenden secuencias de cadena ligera sustitutas de anticuerpos.
|
CN101687921A
(zh)
|
2007-05-11 |
2010-03-31 |
淡马锡生命科学研究院有限公司 |
可用于h5禽流感诊断和监视的h5亚型特异性结合蛋白
|
US20090252729A1
(en)
|
2007-05-14 |
2009-10-08 |
Farrington Graham K |
Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
|
WO2008156763A2
(en)
|
2007-06-15 |
2008-12-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human neutralizing monoclonal antibodies to h5n1 influenza a virus
|
EP2716656B1
(en)
|
2007-06-15 |
2016-10-12 |
Xiamen University |
Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
|
WO2009035420A1
(en)
|
2007-09-13 |
2009-03-19 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof
|
JP5490695B2
(ja)
|
2007-09-13 |
2014-05-14 |
テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド |
インフルエンザウイルスh5亜型からのヘマグルチニンに特異的なモノクローナル抗体およびそれらの使用
|
FR2921928B1
(fr)
|
2007-10-08 |
2011-03-04 |
Sanofi Pasteur |
Anticorps monoclonaux specifiques de l'hemagglutinine du virus grippal
|
AU2008331673B2
(en)
|
2007-11-12 |
2014-12-11 |
The Trustees Of The University Of Pennsylvania |
Novel vaccines against multiple subtypes of influenza virus
|
WO2009073163A1
(en)
|
2007-12-03 |
2009-06-11 |
American Type Culture Collection (Atcc) |
Avian influenza antibodies, compositions, and methods thereof
|
EP3333187B1
(en)
|
2007-12-06 |
2022-06-22 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
US7981428B2
(en)
|
2008-01-23 |
2011-07-19 |
Academia Sinica |
Flu vaccines and methods of use thereof
|
JP5490725B2
(ja)
|
2008-02-05 |
2014-05-14 |
テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド |
H5亜型インフルエンザウイルスの普遍的な検出のための結合タンパク質およびエピトープブロッキングelisa
|
EP2265646B1
(en)
|
2008-03-12 |
2016-01-27 |
Her Majesty, The Queen in Right of Canada, as Represented by The Minister of Health |
Reagents and methods for detecting influenza virus proteins
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
EP2698380A1
(en)
|
2008-03-28 |
2014-02-19 |
Sea Lane Biotechnologies, LLC |
Neutralizing molecules to viral antigens
|
CN101990575B
(zh)
|
2008-03-28 |
2015-06-17 |
国立大学法人北海道大学 |
抗h5亚型a型流感病毒血凝素单克隆抗体
|
FI20080333A0
(fi)
|
2008-05-02 |
2008-05-02 |
Glykos Finland Oy |
Influenssaviruksen nukleiinihappoja ja peptidejä
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
SI2285408T1
(sl)
|
2008-06-05 |
2019-02-28 |
Ablynx N.V. |
Aminokislinska zaporedja usmerjena proti proteinom ovojnicam virusa in polipeptidi, ki zaporedja vsebujejo za zdravljenje virusnih bolezni
|
AU2009268576B2
(en)
|
2008-07-11 |
2014-03-27 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
JP5607620B2
(ja)
|
2008-07-25 |
2014-10-15 |
インスティテュート・フォー・リサーチ・イン・バイオメディシン |
抗a型インフルエンザウイルス中和抗体およびその使用
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
CA2736799A1
(en)
|
2008-08-25 |
2010-03-11 |
Burnham Institute For Medical Research |
Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use
|
US20100061995A1
(en)
|
2008-09-08 |
2010-03-11 |
Damian Michael Carragher |
Immunotherapy To Treat Or Prevent Viral Infection
|
GB0818356D0
(en)
|
2008-10-07 |
2008-11-12 |
Istituto Superiore Di Sanito |
Antibodies
|
WO2010040281A1
(zh)
|
2008-10-09 |
2010-04-15 |
厦门大学 |
H5亚型禽流感病毒血凝蛋白的人源化抗体及其用途
|
CA2740138C
(en)
|
2008-10-22 |
2017-01-10 |
Institute For Research In Biomedicine |
Methods for producing antibodies from plasma cells
|
SG172333A1
(en)
|
2008-12-24 |
2011-07-28 |
Temasek Life Sciences Lab Ltd |
Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza a viruses and uses thereof
|
CN102264896B
(zh)
|
2008-12-25 |
2014-02-26 |
国立大学法人大阪大学 |
抗人流感病毒人型抗体
|
US8894997B2
(en)
|
2009-04-30 |
2014-11-25 |
Vanderbilt University |
Monoclonal antibodies to influenza H1N1 virus uses thereof
|
NZ596032A
(en)
|
2009-05-11 |
2013-09-27 |
Crucell Holland Bv |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
EP2430047B1
(en)
|
2009-05-13 |
2018-03-28 |
i2 Pharmaceuticals, Inc. |
Neutralizing molecules to influenza viruses
|
IT1395961B1
(it)
|
2009-06-01 |
2012-11-02 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
|
AU2010266129B2
(en)
|
2009-07-02 |
2016-04-14 |
Massachusetts Institute Of Technology |
Compositions and methods for diagnosing and/or treating influenza infection
|
WO2011019932A2
(en)
|
2009-08-14 |
2011-02-17 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
WO2011041391A1
(en)
|
2009-09-29 |
2011-04-07 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
US9458226B2
(en)
|
2009-10-09 |
2016-10-04 |
Emory University |
Recombinant antibodies against H1N1 influenza
|
WO2011068143A1
(ja)
|
2009-12-03 |
2011-06-09 |
独立行政法人科学技術振興機構 |
H5亜型インフルエンザウイルスに対する抗体およびその利用
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
CA2787940C
(en)
|
2010-01-27 |
2020-01-07 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
WO2011093217A1
(ja)
|
2010-01-29 |
2011-08-04 |
富士レビオ株式会社 |
抗Pandemic (H1N1) 2009抗体及びそれを用いた免疫測定方法
|
JPWO2011096302A1
(ja)
|
2010-02-02 |
2013-06-10 |
国立大学法人名古屋大学 |
薬剤耐性インフルエンザウイルス特異的抗体及びその用途
|
JP2011160681A
(ja)
|
2010-02-05 |
2011-08-25 |
Japan Science & Technology Agency |
A型インフルエンザのヘマグルチニンに対する抗体およびその利用
|
MX338758B
(es)
|
2010-03-08 |
2016-04-29 |
Celltrion Inc |
Anticuerpos monoclonales humanos, derivados de celulas b humanas, y que tienen actividad neutralizante contra el virus de la influenza a.
|
EA029198B1
(ru)
|
2010-03-26 |
2018-02-28 |
Помона Ричерка С.Р.Л. |
Полноразмерные иммуноглобулины изотипа igg, способные к распознаванию нейтрализующего эпитопа в области стебля гемагглютинина различных подтипов и их использование в качестве лекарственного средства против гриппа
|
KR101849738B1
(ko)
|
2010-06-17 |
2018-04-17 |
트렐리스 바이오싸이언스 인코포레이티드 |
수동 인플루엔자 면역에 유용한 항체
|
JP2013540701A
(ja)
|
2010-08-12 |
2013-11-07 |
セラクローン サイエンシーズ, インコーポレイテッド |
抗赤血球凝集素抗体組成物およびその使用方法
|
EP2609113B1
(en)
|
2010-08-23 |
2017-03-22 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
US8802110B2
(en)
|
2010-09-21 |
2014-08-12 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
|
US20130289246A1
(en)
|
2010-09-30 |
2013-10-31 |
Vanderbilt University |
Influenza virus antibodies and immunogens and uses therefor
|
CA2813078A1
(en)
|
2010-10-04 |
2012-04-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
WO2012054745A1
(en)
|
2010-10-20 |
2012-04-26 |
New York Blood Center, Inc. |
Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection
|
EP2646050B1
(en)
|
2010-12-02 |
2016-09-07 |
mAB-Factory GmbH |
Vaccine against influenza h5n1 viruses, medicament and treatment of h5n1 viral infections
|
WO2012096994A2
(en)
|
2011-01-10 |
2012-07-19 |
Emory University |
Antibodies directed against influenza
|
ES2608321T3
(es)
|
2011-07-14 |
2017-04-07 |
Janssen Vaccines & Prevention B.V. |
Moléculas de unión humanas capaces de neutralizar virus de la gripe A del grupo filogenético 1 y del grupo filogenético 2 y virus de la gripe B
|
PL3418300T3
(pl)
|
2011-07-18 |
2021-05-04 |
Institute For Research In Biomedicine |
Neutralizujące przeciwciała przeciwko wirusowi grypy A i ich zastosowania
|
EP2739312B1
(en)
|
2011-08-03 |
2017-10-04 |
Children's Medical Center Corporation |
A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
|
GB201115214D0
(en)
|
2011-09-02 |
2011-10-19 |
Health Prot Agency |
Influenza virus antibody compositions
|
CA2900712A1
(en)
|
2011-09-30 |
2013-04-04 |
Celltrion Inc. |
Binding molecule having influenza a virus-neutralizing activity produced from human b cell
|
WO2013044840A1
(zh)
|
2011-09-30 |
2013-04-04 |
中国科学院上海巴斯德研究所 |
高致病性禽流感的中和分子及其制备方法
|
US9321829B2
(en)
|
2011-10-18 |
2016-04-26 |
Emory University |
Antibodies directed against influenza
|
KR20130059721A
(ko)
|
2011-11-29 |
2013-06-07 |
(주)셀트리온 |
인간 b 세포에서 생산된 인플루엔자 a 바이러스 중화 활성을 가지는 결합 분자
|
JP6325451B2
(ja)
|
2011-12-02 |
2018-05-16 |
アイム・セラピューティクス・べー・フェー |
A型インフルエンザに特異的な抗体
|
US10654915B2
(en)
|
2011-12-05 |
2020-05-19 |
Trellis Bioscience, Llc |
Antibodies useful in passive influenza immunization
|
WO2013089496A1
(ko)
|
2011-12-15 |
2013-06-20 |
(주)에이프로젠 |
H1n1-감염된 환자들로부터 유도된 매우 잠재력 있는 넓은-스펙트럼 중화 단일클론 항체 및 이를 포함하는 바이러스의 치료용 조성물
|
WO2013114885A1
(en)
|
2012-01-31 |
2013-08-08 |
Osaka University |
Human monoclonal antibodies broadly protective against influenza b virus and methods of using the same
|
CA2865594C
(en)
|
2012-03-08 |
2021-07-27 |
Crucell Holland B.V. |
Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
|
SG11201406769RA
(en)
|
2012-05-10 |
2014-11-27 |
Massachusetts Inst Technology |
Agents for influenza neutralization
|
US9969794B2
(en)
*
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
US20140335504A1
(en)
|
2013-02-07 |
2014-11-13 |
Massachusetts Institute Of Technology |
Human adaptation of h5 influenza
|
AU2014329609B2
(en)
|
2013-10-02 |
2019-09-12 |
Humabs Biomed Sa |
Neutralizing anti-influenza A antibodies and uses thereof
|
RU2682049C2
(ru)
|
2014-01-27 |
2019-03-14 |
Дженентек, Инк. |
Лечение вируса гриппа а h7n9
|
EP3374390A1
(en)
|
2015-11-13 |
2018-09-19 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
CA3015347A1
(en)
|
2016-02-24 |
2017-08-31 |
Visterra, Inc. |
Formulations of antibody molecules to influenza virus
|
WO2020198329A1
(en)
*
|
2019-03-25 |
2020-10-01 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|